All the news Showing 10 of 448 articles from: TherapiesGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources European CHMP Adopts Positive Opinion for Gilead’s Vosevi® (Sofosbuvir/Velpatasvir/Voxilaprevir) for the Treatment of All Chronic Hepatitis C Genotypes Gilead press release / 26 June 2017 AbbVie Receives CHMP Positive Opinion for MAVIRET™ (glecaprevir/pibrentasvir) for the Treatment of Chronic Hepatitis C in All Major Genotypes (GT1-6) AbbVie press release / 26 June 2017 Regulus Discontinuing Development of RG-101 for HCV Regulus press release / 13 June 2017 Early Access to Medicines Scheme (EAMS) Granted to AbbVie’s Investigational Pan-genotypic Regimen for Chronic Hepatitis C in UK AbbVie press release / 10 May 2017 China FDA Approves Country’s First All-Oral Regimen for Chronic Hepatitis C, Daklinza® (daclatasvir) in Combination with Sunvepra® (asunaprevir) Bristol-Myers Squibb / 02 May 2017 Gilead Announces SVR12 Rates From Four Phase 3 Studies of a Once-Daily, Fixed-Dose Combination of Sofosbuvir, Velpatasvir and Voxilaprevir Gilead press release / 27 October 2016 Sofosbuvir/velpatasvir in chronic hepatitis C: hint of added benefit in two of ten subindications IQWIG / 17 October 2016 Achillion Announces 100% SVR12 in the 6-Week and 8-Week Cohorts in Janssen’s Phase 2 Trial Evaluating the Triple Combination Treatment Regimen Including Odalasvir, AL-335, and Simeprevir for Genotype 1 Treatment-Naïve HCV Achillion press release / 26 September 2016 NICE says yes to another hepatitis C drug NICE / 26 September 2016 Exviera, Viekirax regimen shows high SVR in HCV genotype 1b after 8 weeks Healio / 26 September 2016 ← Prev12345...45Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Transmission and prevention Diagnosis and monitoring Disease course and symptoms HCV and coinfections Living with HCV Treatment issues Side effects Therapies Liver transplants Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive